The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hypertension Drugs-Global Market Insights and Sales Trends 2024
Synopsis
The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These definitions apply to adults who are healthy and not using medication for high blood pressure. If the two pressures fall in different categories, the higher one is used to determine the severity of hypertension.
The global Hypertension Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hypertension Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Hypertension Drugs market. Calcium Channel Blockers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diuretics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hypertension Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hypertension Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hypertension Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hypertension Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hypertension Drugs covered in this report include Novartis, Daiichi Sankyo, Actelion Pharmaceuticals, Boehringer Ingelheim and Pfizer, etc.
The global Hypertension Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Daiichi Sankyo
Actelion Pharmaceuticals
Boehringer Ingelheim
Pfizer
Global Hypertension Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hypertension Drugs market, Segment by Type:
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors
Global Hypertension Drugs market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hypertension Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hypertension Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These definitions apply to adults who are healthy and not using medication for high blood pressure. If the two pressures fall in different categories, the higher one is used to determine the severity of hypertension.
The global Hypertension Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Hypertension Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Hypertension Drugs market. Calcium Channel Blockers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Diuretics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hypertension Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hypertension Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hypertension Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hypertension Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hypertension Drugs covered in this report include Novartis, Daiichi Sankyo, Actelion Pharmaceuticals, Boehringer Ingelheim and Pfizer, etc.
The global Hypertension Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Daiichi Sankyo
Actelion Pharmaceuticals
Boehringer Ingelheim
Pfizer
Global Hypertension Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hypertension Drugs market, Segment by Type:
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors
Global Hypertension Drugs market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hypertension Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hypertension Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hypertension Drugs Market Overview
1.1 Hypertension Drugs Product Overview
1.2 Hypertension Drugs Market Segment by Type
1.2.1 Calcium Channel Blockers
1.2.2 Diuretics
1.2.3 Beta Blockers Vasodilators
1.2.4 Angiotensin Converting Enzyme Inhibitors
1.2.5 Alpha Blockers
1.2.6 Angiotensin Receptor Blockers
1.2.7 Renin Inhibitors
1.3 Global Hypertension Drugs Market Size by Type
1.3.1 Global Hypertension Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Hypertension Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hypertension Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hypertension Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hypertension Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hypertension Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hypertension Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hypertension Drugs Sales Breakdown by Type (2018-2023)
2 Global Hypertension Drugs Market Competition by Company
2.1 Global Top Players by Hypertension Drugs Sales (2018-2023)
2.2 Global Top Players by Hypertension Drugs Revenue (2018-2023)
2.3 Global Top Players by Hypertension Drugs Price (2018-2023)
2.4 Global Top Manufacturers Hypertension Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hypertension Drugs Market Competitive Situation and Trends
2.5.1 Hypertension Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hypertension Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hypertension Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Hypertension Drugs Market
2.8 Key Manufacturers Hypertension Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hypertension Drugs Status and Outlook by Region
3.1 Global Hypertension Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hypertension Drugs Historic Market Size by Region
3.2.1 Global Hypertension Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Hypertension Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Hypertension Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hypertension Drugs Forecasted Market Size by Region
3.3.1 Global Hypertension Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Hypertension Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Hypertension Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hypertension Drugs by Application
4.1 Hypertension Drugs Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Hypertension Drugs Market Size by Application
4.2.1 Global Hypertension Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Hypertension Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hypertension Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hypertension Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hypertension Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hypertension Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hypertension Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hypertension Drugs Sales Breakdown by Application (2018-2023)
5 North America Hypertension Drugs by Country
5.1 North America Hypertension Drugs Historic Market Size by Country
5.1.1 North America Hypertension Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hypertension Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Hypertension Drugs Sales in Value by Country (2018-2023)
5.2 North America Hypertension Drugs Forecasted Market Size by Country
5.2.1 North America Hypertension Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Hypertension Drugs Sales in Value by Country (2024-2029)
6 Europe Hypertension Drugs by Country
6.1 Europe Hypertension Drugs Historic Market Size by Country
6.1.1 Europe Hypertension Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hypertension Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Hypertension Drugs Sales in Value by Country (2018-2023)
6.2 Europe Hypertension Drugs Forecasted Market Size by Country
6.2.1 Europe Hypertension Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Hypertension Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Hypertension Drugs by Region
7.1 Asia-Pacific Hypertension Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Hypertension Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hypertension Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hypertension Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hypertension Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Hypertension Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hypertension Drugs Sales in Value by Region (2024-2029)
8 Latin America Hypertension Drugs by Country
8.1 Latin America Hypertension Drugs Historic Market Size by Country
8.1.1 Latin America Hypertension Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hypertension Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hypertension Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Hypertension Drugs Forecasted Market Size by Country
8.2.1 Latin America Hypertension Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hypertension Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Hypertension Drugs by Country
9.1 Middle East and Africa Hypertension Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Hypertension Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hypertension Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hypertension Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hypertension Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Hypertension Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hypertension Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Hypertension Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Hypertension Drugs Products Offered
10.1.5 Novartis Recent Development
10.2 Daiichi Sankyo
10.2.1 Daiichi Sankyo Company Information
10.2.2 Daiichi Sankyo Introduction and Business Overview
10.2.3 Daiichi Sankyo Hypertension Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Daiichi Sankyo Hypertension Drugs Products Offered
10.2.5 Daiichi Sankyo Recent Development
10.3 Actelion Pharmaceuticals
10.3.1 Actelion Pharmaceuticals Company Information
10.3.2 Actelion Pharmaceuticals Introduction and Business Overview
10.3.3 Actelion Pharmaceuticals Hypertension Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Actelion Pharmaceuticals Hypertension Drugs Products Offered
10.3.5 Actelion Pharmaceuticals Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information
10.4.2 Boehringer Ingelheim Introduction and Business Overview
10.4.3 Boehringer Ingelheim Hypertension Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Boehringer Ingelheim Hypertension Drugs Products Offered
10.4.5 Boehringer Ingelheim Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Hypertension Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Hypertension Drugs Products Offered
10.5.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hypertension Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hypertension Drugs Industrial Chain Analysis
11.4 Hypertension Drugs Market Dynamics
11.4.1 Hypertension Drugs Industry Trends
11.4.2 Hypertension Drugs Market Drivers
11.4.3 Hypertension Drugs Market Challenges
11.4.4 Hypertension Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hypertension Drugs Distributors
12.3 Hypertension Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
